Medical records of patients with suspected AILD who had positive cytoplasmic ANA patterns between February 2017 and November 2019 were retrospectively reviewed for clinical, laboratory, and immunological data. The gene discussed is BTG3; the disease is angioimmunoblastic T-cell lymphoma.